DG Capital Management (Massachusetts)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | $1.15M | Buy |
+2,850
| New | +$1.15M | 1.13% | 39 |
|
|
2016
Q1 | – | Sell |
-2,980
| Closed | -$1.62M | – | 73 |
|
|
2015
Q4 | $1.62M | Sell |
2,980
-1,955
| -40% | -$1.06M | 1.44% | 30 |
|
|
2015
Q3 | $2.3M | Buy |
4,935
+280
| +6% | +$130K | 1.55% | 30 |
|
|
2015
Q2 | $2.38M | Sell |
4,655
-1,025
| -18% | -$523K | 1.43% | 35 |
|
|
2015
Q1 | $2.56M | Buy |
5,680
+2,270
| +67% | +$1.02M | 1.54% | 28 |
|
|
2014
Q4 | $1.4M | Sell |
3,410
-550
| -14% | -$226K | 0.81% | 55 |
|
|
2014
Q3 | $1.43M | Sell |
3,960
-2,758
| -41% | -$995K | 0.87% | 49 |
|
|
2014
Q2 | $1.9M | Sell |
6,718
-5,030
| -43% | -$1.42M | 1.08% | 49 |
|
|
2014
Q1 | $3.53M | Sell |
11,748
-2,510
| -18% | -$754K | 2.09% | 17 |
|
|
2013
Q4 | $3.92M | Buy |
14,258
+975
| +7% | +$268K | 2.19% | 21 |
|
|
2013
Q3 | $4.16M | Buy |
+13,283
| New | +$4.16M | 2.36% | 7 |
|